Literature DB >> 25410857

Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis.

Zekun Wang1, Mohammad A Mir2.   

Abstract

UNLABELLED: Pathogenic hantaviruses delay the type I interferon response during early stages of viral infection. However, the robust interferon response and induction of interferon-stimulated genes observed during later stages of hantavirus infection fail to combat the virus replication in infected cells. Protein kinase R (PKR), a classical interferon-stimulated gene product, phosphorylates the eukaryotic translation initiation factor eIF2α and causes translational shutdown to create roadblocks for the synthesis of viral proteins. The PKR-induced translational shutdown helps host cells to establish an antiviral state to interrupt virus replication. However, hantavirus-infected cells do not undergo translational shutdown and fail to establish an antiviral state during the course of viral infection. In this study, we showed for the first time that Andes virus infection induced PKR overexpression. However, the overexpressed PKR was not active due to a significant inhibition of autophosphorylation. Further studies revealed that Andes virus nucleocapsid protein inhibited PKR dimerization, a critical step required for PKR autophosphorylation to attain activity. The studies reported here establish a hantavirus nucleocapsid protein as a new PKR inhibitor. These studies provide mechanistic insights into hantavirus resistance to the host interferon response and solve the puzzle of the lack of translational shutdown observed in hantavirus-infected cells. The sensitivity of hantavirus replication to PKR has likely imposed a selective evolutionary pressure on hantaviruses to evade the PKR antiviral response for survival. We envision that evasion of the PKR antiviral response by NP has likely helped hantaviruses to exist during evolution and to survive in infected hosts with a multifaceted antiviral defense. IMPORTANCE: Protein kinase R (PKR), a versatile antiviral host factor, shuts down the translation machinery upon activation in virus-infected cells to create hurdles for the manufacture of viral proteins. The studies reported here reveal that the hantavirus nucleocapsid protein counteracts the PKR antiviral response by inhibiting PKR dimerization, which is required for its activation. We report the discovery of a new PKR inhibitor whose expression in hantavirus-infected cells prevents the PKR-induced host translational shutdown to ensure the continuous synthesis of viral proteins required for efficient virus replication.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410857      PMCID: PMC4300761          DOI: 10.1128/JVI.02347-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA.

Authors:  C Löber; B Anheier; S Lindow; H D Klenk; H Feldmann
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

2.  Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy.

Authors:  Peng H Tan; Shao-An Xue; Maria Manunta; Sven C Beutelspacher; Henrieta Fazekasova; A K M Shamsul Alam; Myra O McClure; Andrew J T George
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-15       Impact factor: 8.311

3.  Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation.

Authors:  S Nanduri; B W Carpick; Y Yang; B R Williams; J Qin
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

4.  The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity.

Authors:  M W Melville; S L Tan; M Wambach; J Song; R I Morimoto; M G Katze
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

5.  Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition.

Authors:  Madhusudan Dey; Chune Cao; Arvin C Dar; Tomohiko Tamura; Keiko Ozato; Frank Sicheri; Thomas E Dever
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

6.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

7.  Antagonism of type I interferon responses by new world hantaviruses.

Authors:  Jessica R Levine; Joseph Prescott; Kyle S Brown; Sonja M Best; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

8.  Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

Authors:  Peng H Tan; Sven C Beutelspacher; Shao-An Xue; Yao-He Wang; Peter Mitchell; James C McAlister; D Frank P Larkin; Myra O McClure; Hans J Stauss; Mary A Ritter; Giovanna Lombardi; Andrew J T George
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

9.  In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.

Authors:  Brian D Brown; Giovanni Sitia; Andrea Annoni; Ehud Hauben; Lucia Sergi Sergi; Anna Zingale; Maria Grazia Roncarolo; Luca G Guidotti; Luigi Naldini
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

10.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more
  14 in total

1.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  The nucleocapsid protein of hantaviruses: much more than a genome-wrapping protein.

Authors:  Monika Reuter; Detlev H Krüger
Journal:  Virus Genes       Date:  2017-11-20       Impact factor: 2.332

3.  Puumala and Andes Orthohantaviruses Cause Transient Protein Kinase R-Dependent Formation of Stress Granules.

Authors:  Wanda Christ; Janne Tynell; Jonas Klingström
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

4.  Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication.

Authors:  Zekun Wang; Xuefeng Deng; Wei Zou; John F Engelhardt; Ziying Yan; Jianming Qiu
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  Hantavirus RdRp Requires a Host Cell Factor for Cap Snatching.

Authors:  Subbiah Jeeva; Sheema Mir; Adrain Velasquez; Brandy A Weathers; Aljona Leka; Sharon Wu; Ariga Tahmasian Sevarany; Mohammad Mir
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

6.  Parvovirus Expresses a Small Noncoding RNA That Plays an Essential Role in Virus Replication.

Authors:  Zekun Wang; Weiran Shen; Fang Cheng; Xuefeng Deng; John F Engelhardt; Ziying Yan; Jianming Qiu
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 7.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

Review 8.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 9.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

Review 10.  What Do We Know about How Hantaviruses Interact with Their Different Hosts?

Authors:  Myriam Ermonval; Florence Baychelier; Noël Tordo
Journal:  Viruses       Date:  2016-08-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.